Research and strategy for consequential decisions
We hold the intelligence, you lead the era.
LibraVek balances science, markets, and regulation as the domain evolves, so confident strategic decisions become possible. Deep analysis. Clear strategy. Faster results.
Why LibraVek exists
The gap between knowing and deciding
Most organizations are not short on information. They are short on conviction: the clear, defensible line from evidence to action.
Decisions outrun the data
High-stakes calls are made on intelligence that was assembled months ago, for a slightly different question. By the time a report lands, the landscape it describes has moved.
Volume masquerades as insight
Dashboards, feeds, and hundred-page decks create the feeling of coverage. What leadership actually needs is one page of what matters and why, with the evidence behind it.
Generic research answers nobody's question
Off-the-shelf reports are written for a market, not for your decision. The delta between the two is exactly where opportunities are won and lost.
How we work
From raw data to recommendation
Four disciplined steps, run in sequence, tuned to the decision on your table.
-
Gather evidence
We aggregate the global record: patents, scientific literature, market signals, and regulatory movement, combining primary and secondary research.
-
Validate with experts
We pressure-test what the data suggests against practitioners, technical specialists, and the people closest to your customers.
-
Analyze and synthesize
Our analysts pair AI-assisted analysis with human judgment, separating durable trends from noise until a clear picture holds.
-
Recommend action
We deliver a strategic roadmap you can defend in the boardroom: what to do, in what order, and the evidence for each step.
What we do
Capabilities
Six practices, one standard: every engagement ends in a decision you can act on.
-
01
Innovation Strategy
Align R&D priorities and go-to-market plans with where technology and demand are actually heading, not where last year's roadmap assumed.
-
02
Technology Scouting
Surface emerging technologies, startups, and partners before they appear in competitors' plans, with a reasoned view on maturity and fit.
-
03
Market & Competitive Intelligence
Track market shifts and competitor moves through analysis built around your specific decisions, not a generic category report.
-
04
Due Diligence
Support M&A, licensing, and investment decisions with rigorous technical and market analysis that holds up under scrutiny.
-
05
Regulatory & Standards Research
Monitor regulations, standards, and policy across markets so change arrives as a planned move, not a surprise.
-
06
Consumer Insights & Claim Validation
Test product claims and gauge real customer sentiment with evidence you can stand behind, in front of regulators and buyers alike.
Who you are working with
Why LibraVek
We built the firm we always wanted to hire: researchers who argue from evidence, and strategists who finish the sentence, all the way to what you should do next.
Evidence-backed, or we say so
Every recommendation is grounded in data and expert validation. When the evidence is thin, you hear that too, along with what it would take to firm it up.
Cross-industry depth
Deep experience across food and beverage, CPG, life sciences, and technology, researched with a genuinely global lens.
Built for the decision, not the deliverable
Our work ends where your action plan begins. Clear next steps, sequenced and defensible, not a deck that needs its own analyst.
From the ThinkTank
Latest insights
GLP-1 Booster Supplements: Real Science or Borrowed Hype?
What every Indian manufacturer needs to understand before entering the GLP-1 supplement market: the science, the regulatory line, and where the two diverge.
Green Tea: Booming in India, Restricted in Europe
The same green tea extract capsule can carry a weight-management claim in India and be barred from that claim in Europe. That gap is a compliance risk the moment you cross a border.
Switching to Recyclable Food-Contact Plastic? Think, Then Decide.
Sustainable packaging and safe packaging are not the same thing. The gap between the two is exactly where regulatory risk lives.
Bring us the question